Mexico Thyroid Eye Disease Market Size & Outlook, 2026-2034


Mexico Thyroid Eye Disease Market Insights

  • As per Reed Intelligence insights, the Mexico Thyroid Eye Disease Market stood at USD 34.73 Million in 2025 and is anticipated to grow to USD 63.38 Million by 2034.
  • The Mexico market is expected to advance at a CAGR of 6.9% from 2026 through 2034.
  • In 2025, Biologics accounted for the highest share of the Therapy Type market size.
  • During the forecast period, Small Molecule Drugs is set to register the highest growth, making it the most lucrative Therapy Type segment.

Other Key Findings


  • In 2025, Mexico accounted for 2.94% of the global Thyroid Eye Disease Market size.
  • By 2034, United States is expected to lead the global Thyroid Eye Disease Market in terms of market size.
  • Within LATAM, Brazil is projected to dominate the regional Thyroid Eye Disease Market size by 2034.
  • Chile is identified as the fastest-growing market in LATAM, anticipated to reach USD 16.65 Million by 2034.

Report Summary

Report Scope Details
Base Year for Study 2025
Study Period 2022-2034
Historical Period 2022-2024
Forecast Period 2026-2034
Market Size In 2025 USD 34.73 Million
Market Size In 2034 USD 63.38 Million
Largest segment Biologics
Units Revenue in USD Million
CAGR 6.9% (2026-2034)
Segmnetation Covered
Therapy Type
  1. Biologics
  2. Small Molecule Drugs
  3. Corticosteroids
Treatment Approach
  1. Pharmacological Therapy
  2. Combination Therapy
  3. Surgical Intervention
Distribution Channel
  1. Hospital Pharmacies
  2. Retail Pharmacies
  3. Online Pharmacies
Report Coverage Revenue Forecast, Competitive Landscape, Growth Factors, Environment & Regulatory Landscape and Trends

Related Reports